Alzheimer's Association Holds International Conference

New research reported at the Alzheimer’s Association International Conference (AAIC) 2023 covered the breadth of Alzheimer’s disease and dementia research, including advancements in treatment, early and accurate diagnosis, and risk factors for Alzheimer’s and other dementias.

AAIC is the premier annual forum for presentation and discussion of the latest Alzheimer’s and dementia research.

This year’s conference took place both virtually and in-person in Amsterdam, Netherlands, and attracted more than 10,000 attendees and more than 3,000 scientific presentations.

Advances in treatments and clinical trial results included new, more complete data reported by Eli Lilly about clinical trials of donanemab in early symptomatic Alzheimer's disease.

Two new therapeutic approaches for Alzheimer’s based on CRISPR gene editing were reported at AAIC. Advancements in technology and practice reported for the first time at AAIC 2023 demonstrated the simplicity, transportability and diagnostic value of blood-based biomarkers for Alzheimer’s.